[1] Rutherford A, Davern T, Hay JE, et al. Influence of high body mass index on outcome in acute liver failure[J]. Clin Gastroenterol Hepatol, 2006, 4 (12) : 1544-1549.
|
[2] Nakano H, Nagasaki H, Barama A, et al. The effects of N-acetylcysteine and anti-intercellular adhesion molecule-1 monoclonal antibody against ischemia-reperfusion injury of the rat steatotic liver produced by a choline-methionine-deficient diet[J]. Hepatology, 1997, 26 (3) : 670-678.
|
[3] Federico A, Trappoliere M, Loguercio C, et al. Treatment of patients with non-alcoholic fatty liver disease: current views and perspectives[J]. Dig Liver Dis, 2006, 38 (11) : 789-801.
|
[4] Camara-Lemarroy CR, Guzman-de la Garza FJ, Alarcon-Galvan G, et al. The effects of NMDA receptor antagonists over intestinal ischemia/reperfusion injury in rats[J]. Eur J Pharmacol, 2009, 621 (1-3) : 78-85.
|
[5] Lehmann TG, Wheeler MD, Froh M, et al.Effects of three superoxide dismutase genes delivered with an adenovirus on graft function after transplantation of fatty livers in the rat[J]. Transplantation, 2003, 76 (1) : 28-37.
|
[6]Rensen SS, Slaats Y, Nijhuis J, et al.Increased hepatic my-eloperoxidase activity in obese subjects with nonalcoholicsteatohepatitis[J].Am J Pathol, 2009, 175 (4) :1473-1482.
|
[7]Iniguez M, Dotor J, Feijoo E, et al.Novel pharmacologic strate-gies to protect the liver from ischemia-reperfusion injury[J].Recent Pat Cardiovasc Drug Discov, 2008, 3 (1) :9-18.
|
[8]Romanque P, Diaz A, Tapia G, et al.Delayed ischemic pre-conditioning protects against liver ischemia-reperfusion inju-ry in vivo[J].Transplant Proc, 2010, 42 (5) :1569-1575.
|